A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol.
Brown NF. et al, (2020), Bmc cancer, 20
Oral bisphosphonate use and all-cause mortality in patients with moderate-severe (grade 3B-5D) chronic kidney disease: a population-based cohort study.
Alarkawi D. et al, (2020), J bone miner res
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma.
Thomas A. et al, (2020), Eur j cancer, 124, 131 - 141
Components of the full blood count as risk factors for colorectal cancer detection: a systematic review protocol.
Virdee PS. et al, (2019), Bmj open, 9
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC).
Woodcock VK. et al, (2019), Journal of clinical oncology, 37